Syndromes Without a Name Bring Labs an Uphill Battle
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
In an era when genetic and genomic testing are theoretically affordable and accessible, why do so many patients remain undiagnosed?
From - Diagnostic Testing & Emerging Technologies
The National Comprehensive Cancer Network genetic testing criteria for hereditary cancer miss almost one in five at-risk for…
From - Diagnostic Testing & Emerging Technologies
A single urine spot sample can be used to objectively screen for nonadherence to diabetes medications in the…
From - Diagnostic Testing & Emerging Technologies
Raising the laboratory threshold for identifying potential urinary tract infections (UTIs) may prevent…
From - Diagnostic Testing & Emerging Technologies
Only one in six baby boomers report having been tested for hepatitis C virus (HCV)< despite recommendations for…
From - Diagnostic Testing & Emerging Technologies
One in 20 patients without clinical suspicion of acute myocardial infarction has a high sensitivity cardiac troponin I (hs-cTnI) level greater than…
From - Diagnostic Testing & Emerging Technologies
Serial measurement of high-sensitivity C-reactive protein (hsCRP) levels following acute coronary syndrome may help…